Cardiovascular Risk in NAFLD -- Jörn Schattenberg, MD

European Workshop on NASH in Clinical Practice 2019

Abstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc Steens

HIV DART and Emerging Viruses 2018

A 5 amino-acid insertion in the C-terminal region of HIV-2 integrase impacts phenotypic susceptibility to the five integrase inhibitors- Quentin Le Hingrat

European Meeting on HIV & Hepatitis 2018

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

HIV DART and Emerging Viruses 2016

(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya

INTEREST 2016

PrEP Equity for Black Women - A Dream Deferred” Becoming Reality.pdf

International Workshop on HIV & Women 2024

Program Book | International Viral Hepatitis Elimination Meeting (IVHEM) 2023

Hepatitis C Management in Special Populations - Mark Nelson, MD

Tokyo Hepatitis Clinical Forum 2019

Update on HIV drug resistance - Jonathan Schapiro, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2014

Update on Antiviral Agents for Patients with Limited Treatment Options: Clinical Trials and Real-World Data | Antonella Castagna

European HIV Clinical Forum 2023